Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Chiarle

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Nature Cancer|July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancerInes Mota, Enrico Patrucco, Cristina Mastini, et al.
Science Translational Medicine|June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphomaCristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Blood|January 9, 2024
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosisIlaria Crespiatico, Mattia Zaghi, Cristina Mastini, et al.
Blood|June 24, 2020
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphomaNina Prokoph, Nicola A Probst, Liam C Lee, et al.
Cell Reports. Medicine|April 2, 2026
Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironmentYao Yu Yeo, Huaying Qiu, Yunhao Bai, et al.
Hemasphere|February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformationChiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Nature Cancer|July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancerInes Mota, Enrico Patrucco, Cristina Mastini, et al.
Science Translational Medicine|June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphomaCristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Blood|January 9, 2024
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosisIlaria Crespiatico, Mattia Zaghi, Cristina Mastini, et al.
Blood|June 24, 2020
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphomaNina Prokoph, Nicola A Probst, Liam C Lee, et al.
Cell Reports. Medicine|April 2, 2026
Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironmentYao Yu Yeo, Huaying Qiu, Yunhao Bai, et al.
Hemasphere|February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformationChiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Pageof 16